
PAREXEL International Corporation (NASDAQ:PRXL) Named Dr. Tsuetaki As Senior Executive Today
Boston, MA 09/05/2014 (wallstreetpr) – PAREXEL International Corporation (NASDAQ:PRXL), a global leader in biopharmaceutical services, announced its new Senior Vice President for PAREXEL Consulting and Per/Post-Approval













